BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 10728913)

  • 1. Molecular basis of pituitary oncogenesis.
    Tada M; Kobayashi H; Moriuchi T
    J Neurooncol; 1999; 45(1):83-96. PubMed ID: 10728913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pituitary adenoma: mechanisms of endocrine oncogenesis].
    Bertherat J; Bertagna X
    Rev Prat; 1996 Jun; 46(12):1473-81. PubMed ID: 8881160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. G protein abnormalities in pituitary adenomas.
    Spada A; Lania A; Ballarè E
    Mol Cell Endocrinol; 1998 Jul; 142(1-2):1-14. PubMed ID: 9783897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two different pituitary adenomas in a patient with multiple endocrine neoplasia type 1 associated with growth hormone-releasing hormone-producing pancreatic tumor: clinical and genetic features.
    Shintani Y; Yoshimoto K; Horie H; Sano T; Kanesaki Y; Hosoi E; Yokogoshi Y; Bando H; Iwahana H; Kannuki S
    Endocr J; 1995 Jun; 42(3):331-40. PubMed ID: 7670561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal transduction mechanisms in pituitary adenomas.
    Barlier A; Pellegrini-Bouiller I; Caccavelli L; Gunz G; Morange-Ramos I; Jaquet P; Enjalbert A
    Horm Res; 1997; 47(4-6):227-34. PubMed ID: 9167956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations of the MEN1 tumor suppressor gene in pituitary tumors.
    Zhuang Z; Ezzat SZ; Vortmeyer AO; Weil R; Oldfield EH; Park WS; Pack S; Huang S; Agarwal SK; Guru SC; Manickam P; Debelenko LV; Kester MB; Olufemi SE; Heppner C; Crabtree JS; Burns AL; Spiegel AM; Marx SJ; Chandrasekharappa SC; Collins FS; Emmert-Buck MR; Liotta LA; Asa SL; Lubensky IA
    Cancer Res; 1997 Dec; 57(24):5446-51. PubMed ID: 9407947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth factors and human pituitary adenomas.
    Spada A; Lania A
    Mol Cell Endocrinol; 2002 Nov; 197(1-2):63-8. PubMed ID: 12431797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic basis of pituitary adenoma invasiveness: a review.
    Suhardja A; Kovacs K; Rutka J
    J Neurooncol; 2001 May; 52(3):195-204. PubMed ID: 11519849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular pathogenesis of pituitary adenomas: a review.
    Suhardja AS; Kovacs KT; Rutka JT
    Acta Neurochir (Wien); 1999; 141(7):729-36. PubMed ID: 10481784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the MEN1 gene in sporadic pituitary adenomas.
    Schmidt MC; Henke RT; Stangl AP; Meyer-Puttlitz B; Stoffel-Wagner B; Schramm J; von Deimling A
    J Pathol; 1999 Jun; 188(2):168-73. PubMed ID: 10398160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative analysis of growth-related factors in human pituitary adenomas. Lowered insulin-like growth factor-I and its receptor mRNA in growth hormone-producing adenomas.
    Otsuka F; Tamiya T; Yamauchi T; Ogura T; Ohmoto T; Makino H
    Regul Pept; 1999 Aug; 83(1):31-8. PubMed ID: 10498342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular screening of pituitary adenomas for gene mutations and rearrangements.
    Herman V; Drazin NZ; Gonsky R; Melmed S
    J Clin Endocrinol Metab; 1993 Jul; 77(1):50-5. PubMed ID: 8100831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations of the MEN1 tumor suppressor gene in sporadic pituitary tumors.
    Wenbin C; Asai A; Teramoto A; Sanno N; Kirino T
    Cancer Lett; 1999 Jul; 142(1):43-7. PubMed ID: 10424779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pathophysiology of pituitary adenomas.
    Dworakowska D; Grossman AB
    Best Pract Res Clin Endocrinol Metab; 2009 Oct; 23(5):525-41. PubMed ID: 19945021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatostatin receptor subtype gene expression in pituitary adenomas.
    Miller GM; Alexander JM; Bikkal HA; Katznelson L; Zervas NT; Klibanski A
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1386-92. PubMed ID: 7714115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular screening for somatic mutations in corticotropic adenomas of dogs with pituitary-dependent hyperadrenocorticism.
    van Wijk PA; Rijnberk A; Croughs RJ; Meij BP; van Leeuwen IS; Sprang EP; Mol JA
    J Endocrinol Invest; 1997 Jan; 20(1):1-7. PubMed ID: 9075064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the Gs alpha gene in growth hormone-secreting pituitary adenomas by the polymerase chain reaction-direct sequencing method using paraffin-embedded tissues.
    Hosoi E; Yokogoshi Y; Hosoi E; Horie H; Sano T; Yamada S; Saito S
    Acta Endocrinol (Copenh); 1993 Oct; 129(4):301-6. PubMed ID: 8237246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of DNA (Cytosine-5)-Methyltransferase 1 (DNMT1) And DNA (Cytosine-5)-Methyltransferase 3A (DNMT3A) Is Associated with Aggressive Behavior and Hypermethylation of Tumor Suppressor Genes in Human Pituitary Adenomas.
    Ma HS; Wang EL; Xu WF; Yamada S; Yoshimoto K; Qian ZR; Shi L; Liu LL; Li XH
    Med Sci Monit; 2018 Jul; 24():4841-4850. PubMed ID: 30002361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Genetic changes in human pituitary adenomas].
    Spada A; Lania A
    Minerva Endocrinol; 2003 Mar; 28(1):27-37. PubMed ID: 12621361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pituitary adenoma pathogenesis: an update.
    Rostad S
    Curr Opin Endocrinol Diabetes Obes; 2012 Aug; 19(4):322-7. PubMed ID: 22617628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.